QQQ   415.59 (-1.85%)
AAPL   164.68 (-1.41%)
MSFT   398.93 (-1.32%)
META   479.10 (-4.52%)
GOOGL   153.30 (-1.74%)
AMZN   173.78 (-3.04%)
TSLA   147.27 (-1.77%)
NVDA   771.38 (-8.90%)
AMD   146.30 (-5.66%)
NIO   3.80 (-5.00%)
BABA   68.93 (+0.07%)
T   16.48 (+0.92%)
F   12.07 (+0.08%)
MU   106.32 (-5.01%)
GE   148.12 (-3.15%)
CGC   8.03 (+2.55%)
DIS   112.12 (-0.28%)
AMC   3.18 (+8.90%)
PFE   25.87 (+1.89%)
PYPL   61.86 (-0.39%)
XOM   119.64 (+0.94%)
QQQ   415.59 (-1.85%)
AAPL   164.68 (-1.41%)
MSFT   398.93 (-1.32%)
META   479.10 (-4.52%)
GOOGL   153.30 (-1.74%)
AMZN   173.78 (-3.04%)
TSLA   147.27 (-1.77%)
NVDA   771.38 (-8.90%)
AMD   146.30 (-5.66%)
NIO   3.80 (-5.00%)
BABA   68.93 (+0.07%)
T   16.48 (+0.92%)
F   12.07 (+0.08%)
MU   106.32 (-5.01%)
GE   148.12 (-3.15%)
CGC   8.03 (+2.55%)
DIS   112.12 (-0.28%)
AMC   3.18 (+8.90%)
PFE   25.87 (+1.89%)
PYPL   61.86 (-0.39%)
XOM   119.64 (+0.94%)
QQQ   415.59 (-1.85%)
AAPL   164.68 (-1.41%)
MSFT   398.93 (-1.32%)
META   479.10 (-4.52%)
GOOGL   153.30 (-1.74%)
AMZN   173.78 (-3.04%)
TSLA   147.27 (-1.77%)
NVDA   771.38 (-8.90%)
AMD   146.30 (-5.66%)
NIO   3.80 (-5.00%)
BABA   68.93 (+0.07%)
T   16.48 (+0.92%)
F   12.07 (+0.08%)
MU   106.32 (-5.01%)
GE   148.12 (-3.15%)
CGC   8.03 (+2.55%)
DIS   112.12 (-0.28%)
AMC   3.18 (+8.90%)
PFE   25.87 (+1.89%)
PYPL   61.86 (-0.39%)
XOM   119.64 (+0.94%)
QQQ   415.59 (-1.85%)
AAPL   164.68 (-1.41%)
MSFT   398.93 (-1.32%)
META   479.10 (-4.52%)
GOOGL   153.30 (-1.74%)
AMZN   173.78 (-3.04%)
TSLA   147.27 (-1.77%)
NVDA   771.38 (-8.90%)
AMD   146.30 (-5.66%)
NIO   3.80 (-5.00%)
BABA   68.93 (+0.07%)
T   16.48 (+0.92%)
F   12.07 (+0.08%)
MU   106.32 (-5.01%)
GE   148.12 (-3.15%)
CGC   8.03 (+2.55%)
DIS   112.12 (-0.28%)
AMC   3.18 (+8.90%)
PFE   25.87 (+1.89%)
PYPL   61.86 (-0.39%)
XOM   119.64 (+0.94%)
NYSE:NGVT

Ingevity (NGVT) Stock Price, News & Analysis

$44.10
+0.60 (+1.38%)
(As of 02:43 PM ET)
Today's Range
$43.35
$44.43
50-Day Range
$43.50
$49.17
52-Week Range
$36.66
$72.76
Volume
68,445 shs
Average Volume
220,032 shs
Market Capitalization
$1.60 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$48.75

Ingevity MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
10.2% Upside
$48.75 Price Target
Short Interest
Healthy
1.93% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.64mentions of Ingevity in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
40.82%
From $3.65 to $5.14 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.52 out of 5 stars

Basic Materials Sector

108th out of 172 stocks

Chemicals & Allied Products Industry

10th out of 16 stocks

NGVT stock logo

About Ingevity Stock (NYSE:NGVT)

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products for use in gasoline vapor emission control systems in cars, motorcycles, trucks, and boats. This segment also produces other activated carbon products for food, water, beverage, and chemical purification applications. The Performance Chemicals segment consists of road technologies and industrial specialties. This segment's products are used in pavement construction, pavement preservation, pavement reconstruction and recycling, road markings, agrochemical dispersants, paper chemicals, and other industrial uses. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers for use in coatings, resins, elastomers, adhesives, bioplastics, and medical devices. It serves automotive parts and components manufacturers through sales representatives and distributors. The company was formerly known as WestRock Company, Specialty Chemicals Business and changed its name to Ingevity Corporation in September 2015. Ingevity Corporation was founded in 1964 and is headquartered in North Charleston, South Carolina.

NGVT Stock Price History

NGVT Stock News Headlines

With the “Bitcoin Loophole” you can supercharge the gains by 10x or more
Thanks to this newly discovered Bitcoin Loophole, you can now trade Bitcoin in any regular brokerage account… And not only that… you can use it to supercharge the gains of Bitcoin by 10x or more! You see, thanks to one unique investor's brand new discovery - anyone with a regular brokerage account can now tap into the most explosive asset in history. That means you can skip the hassle of opening a Coinbase account… Bypass the fees and hard-to-remember passwords…
Ingevity (NYSE: NGVT)
NGVT Jun 2024 50.000 call
Bitcoin Rockets To Record High But Buy THIS Instead
Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…
NGVT Apr 2024 45.000 call
Ingevity price target raised by $7 at Wells Fargo, here's why
Ingevity: Hold Rating Amidst Transition and Macroeconomic Uncertainties
Ingevity (NGVT) Q4 Earnings and Revenues Beat Estimates
Ingevity earnings: here's what Wall Street expects
Ingevity's Earnings Outlook
Ingevity Corp.
NGVT: Raising target price to $40.00
See More Headlines
Receive NGVT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ingevity and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/21/2024
Today
4/19/2024
Next Earnings (Confirmed)
5/01/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Chemicals & allied products
Sub-Industry
N/A
Previous Symbol
NASDAQ:NGVT
Employees
1,700
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$48.75
High Stock Price Target
$53.00
Low Stock Price Target
$43.00
Potential Upside/Downside
+10.8%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
4 Analysts

Profitability

Pretax Margin
-0.60%

Debt

Sales & Book Value

Annual Sales
$1.69 billion
Cash Flow
$7.42 per share
Book Value
$17.43 per share

Miscellaneous

Free Float
35,882,000
Market Cap
$1.60 billion
Optionable
Optionable
Beta
1.85
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Mr. John C. Fortson (Age 57)
    President, CEO & Director
    Comp: $1.29M
  • Ms. Mary Dean Hall (Age 66)
    Executive VP & CFO
    Comp: $658.77k
  • Ms. Stacy Lancaster Cozad (Age 53)
    Executive VP, General Counsel & Secretary
    Comp: $615.75k
  • Mr. Stuart Edward Woodcock Jr.Mr. Stuart Edward Woodcock Jr. (Age 58)
    Executive VP & President of Performance Materials
    Comp: $823.8k
  • Mr. Richard A. White Jr. (Age 61)
    Senior VP & President of Performance Chemicals
    Comp: $575.57k
  • Mr. Phillip John Platt (Age 43)
    VP, Chief Accounting Officer & Business Transformation Lead
  • John E. Nypaver Jr.
    VP of Investor Relations & Treasurer
  • Caroline Monahan
    Director of Communications
  • Ms. Christine Stunyo (Age 45)
    Senior VP & Chief Human Resources Officer
  • Mr. Steven P. Hulme (Age 55)
    Senior VP & President of Advanced Polymer Technologies

NGVT Stock Analysis - Frequently Asked Questions

Should I buy or sell Ingevity stock right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ingevity in the last year. There are currently 4 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" NGVT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NGVT, but not buy additional shares or sell existing shares.
View NGVT analyst ratings
or view top-rated stocks.

What is Ingevity's stock price target for 2024?

4 Wall Street research analysts have issued 12-month price targets for Ingevity's stock. Their NGVT share price targets range from $43.00 to $53.00. On average, they predict the company's share price to reach $48.75 in the next year. This suggests a possible upside of 10.2% from the stock's current price.
View analysts price targets for NGVT
or view top-rated stocks among Wall Street analysts.

How have NGVT shares performed in 2024?

Ingevity's stock was trading at $47.22 at the beginning of the year. Since then, NGVT shares have decreased by 6.4% and is now trading at $44.22.
View the best growth stocks for 2024 here
.

When is Ingevity's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024.
View our NGVT earnings forecast
.

How can I listen to Ingevity's earnings call?

Ingevity will be holding an earnings conference call on Thursday, May 2nd at 10:00 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Ingevity's earnings last quarter?

Ingevity Co. (NYSE:NGVT) issued its earnings results on Wednesday, February, 21st. The company reported $0.21 EPS for the quarter, beating the consensus estimate of ($0.13) by $0.34. The business had revenue of $371.70 million for the quarter, compared to analyst estimates of $336.74 million. Ingevity had a positive trailing twelve-month return on equity of 20.75% and a negative net margin of 0.32%. The business's revenue for the quarter was down 3.1% on a year-over-year basis. During the same period last year, the company posted $0.57 EPS.

What guidance has Ingevity issued on next quarter's earnings?

Ingevity issued an update on its FY 2024 earnings guidance on Wednesday, February, 21st. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1.4 billion-$1.6 billion, compared to the consensus revenue estimate of $1.5 billion.

What is John Fortson's approval rating as Ingevity's CEO?

2 employees have rated Ingevity Chief Executive Officer John Fortson on Glassdoor.com. John Fortson has an approval rating of 100% among the company's employees. This puts John Fortson in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Ingevity own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Ingevity investors own include Pfizer (PFE), AbbVie (ABBV), General Electric (GE), Verizon Communications (VZ), WestRock (WRK), Abbott Laboratories (ABT), Boeing (BA), Costco Wholesale (COST), Dominion Energy (D) and Johnson & Johnson (JNJ).

Who are Ingevity's major shareholders?

Ingevity's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Salem Investment Counselors Inc. (0.28%) and Moody National Bank Trust Division (0.06%). Insiders that own company stock include Erik Spencer Ripple, Phillip John Platt, Richard Allen White Jr and Stuart Edward Jr Woodcock.
View institutional ownership trends
.

How do I buy shares of Ingevity?

Shares of NGVT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:NGVT) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners